Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
Evcimen
Yesne Alici
YA
Evcimen
Harun
H
Holland
Jimmie
J
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000068180:Aripiprazole; D018491:Dopamine Agonists / Q000494:pharmacology*; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects*; D013629:Tamoxifen / Q000009:adverse effects / Q000494:pharmacology*
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D010879:Piperazines; D015363:Quinolones; D011954:Receptors, Dopamine; D013629:Tamoxifen; D000068180:Aripiprazole